AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox


Welcome to today's unusual options flow analysis. On November 10, 2025, we tracked $333.5 MILLION in institutional-scale options activity across 10 high-conviction positions. This isn't retail speculation—these are sophisticated players positioning for major catalysts spanning from December 2025 through January 2027.
Today's Total Flow: $333.5M across 10 tickers Largest Single Trade:
Bull Call Spread Average Premium: $33.35M per ticker Timeframe Range: Weekly (Dec) to LEAPS (Jan 2027)- Bullish crypto bet with January 2027 LEAPS as ETF flows surge and Coinbase One subscriptions hit records. Strategy expects consolidation near $300 before breakout above $350 by 2026.
- December 19th expiration targeting $240-$250 as Fed rate cuts accelerate (3 more cuts expected 2025), geopolitical tensions simmer, and dollar weakness creates 10% tailwind for gold.
- Two simultaneous massive trades (7,000 deep ITM + 17,000 ATM calls) betting on Q4 earnings beat, Gemini AI momentum, and Search antitrust resolution by February 2025.
- Buying back puts (closing bullish position) while selling $100 calls as institutional money derisk after 28% YTD rally driven by dollar weakness. ECB cuts to 1.5% by September 2025 expected.
- February 2026 insurance against 10% downturn ahead of June 2025 Russell reconstitution ($70-100B trading volume) as 40% recession probability looms and healthcare crisis deepens.
- Range-bound bet between $26-$28 through December 26 expiration as Versant cable spinoff completes Q4 2025. Strategy profits if stock stays flat during corporate action.
- Sold 23,000 December $200 calls for $20M, bought 27,000 November $200 calls for $7.9M (net $12.1M credit) expecting consolidation near $200 through Nov 21, then breakout by Dec 19 as S&P 500 inclusion drives flows.
- Closed November $135 calls for $4.3M profit, opened 6,100 February 2026 $165 calls for $2.04M positioning for J.P. Morgan Healthcare Conference (Jan 13-16) that generated $8.2B M&A deals in 2024.
- Two trades layering calls at $185 (Jan 2026) and $225 (June 2026) betting S&P 500's best performer (+280% YTD) continues as AI data center nuclear power agreements materialize at 2.4 GW Comanche Peak plant.
- January 2027 $300 strike capturing 14-month upside from $1.88B fresh contracts, Next Gen Jammer production, Golden Dome missile defense awards, and Trump administration defense priorities.
The VST $5.1M dual call position isn't just about one stock—it's a bet on the entire AI infrastructure thesis. With McKinsey projecting AI data centers will consume 13% of global electricity by 2030 (42% CAGR), VST's second-largest U.S. nuclear fleet (6,505 MW) becomes critical infrastructure. The $185 January 2026 calls target near-term data center agreements, while the $225 June 2026 moonshot bets on multi-billion dollar PPAs signing.
What matters: Vistra is actively negotiating nuclear co-location at Comanche Peak (2.4 GW) and Beaver Valley (1.8 GW) with "two large companies" per CEO. After FERC's Amazon-Talen rejection, VST's approach focuses on behind-the-meter solutions. If agreements sign, nuclear becomes premium-priced baseload (vs. intermittent renewables), justifying $225+ targets.
Risk: Already up 280% YTD from ~$49 to $186. Valuation stretched with 4.68 debt-to-equity ratio. Any data center deal delays or Winter Storm Uri repeat could gap stock down 20-30%.
The GLD $96M bull call spread is the largest single trade today, and the December 19th timing is deliberate. Someone paid $96M betting gold rallies 6-9% in just 39 days. Why?
Trade structure: December $240-$250 bull call spread. Max profit if
between $245-$250. Current price $234.85. Needs 2.2-6.4% move—achievable if Fed signals more cuts or geopolitics flare.Risk: Gamma resistance massive at $240 (127.3B exposure). If dollar reverses on U.S. economic strength, gold vulnerable to 5-10% pullback.
The GOOGL $60M dual call strategy combines two massive trades at 10:49 AM—7,000 deep ITM December $130 calls ($15M) + 17,000 ATM December $195 calls ($45M). This isn't hedging. This is aggressive accumulation before catalysts.
Why December expiration?
The PLTR $27.9M calendar spread takes the opposite approach—short December, long November—betting on near-term consolidation followed by post-earnings breakout. Net $12.1M credit collected! Trader profits if PLTR stays near $200 through November 21, keeping sold calls worthless, while bought calls decay slower.
Key insight: Both trades expect Q4 earnings beats but use different structures.
buyer wants immediate upside; PLTR seller wants range-bound action first.The IBB $6.1M calendar roll is a textbook example of professional trade management. Trader closed profitable November $135 calls ($4.3M), then redeployed into 6,100 February 2026 $165 calls ($2.04M net cost). Net $6.04M committed—but they already extracted $4.3M profit!
J.P. Morgan Healthcare Conference (January 13-16, 2025) is the catalyst. The 2024 conference generated $8.2B in M&A deals (vs $2.65B in 2023). With 64% of investors expecting IPO uptick, falling interest rates, and $350-400B patent cliff forcing Big Pharma to acquire pipelines, biotech M&A wave building.
Top holdings catalysts:
Risk: Patent cliff is real ($350-400B revenue at risk through 2030). GLP-1 obesity market consolidating around Novo/Lilly. 39% of small biotechs have <1 year cash runway.
The IWD $8M put spread (buying $185 puts, selling $175 puts for February 2026) and EFA $12.8M complex roll (buying back puts, selling $100 calls) show institutional caution.
Why hedge now?
IWD structure: Protects $1.54B portfolio against 10% decline ($204 → $185) for just $2.8M net cost (0.18% insurance). Max profit if Russell 1000 Value drops to $175 (14.87% decline).
EFA structure: Closing profitable bullish put sales, capping upside at $100 with call sales. After 28.2% YTD rally, taking chips off table.
Near-term volatility expected:
Nov 21 Monthly Expiration:
December 19th Quarterly Expiration (39 days):
Near-term catalysts before Dec 19:
January 2025:
February 2025:
March 2025:
June 2025:
2026-2027:
Key dates summary:
Best Trade: Follow the PLTR $27.9M Calendar Spread structure (but scaled down!)
Your Play:
How you win:
How you lose:
Why this works for YOLO: You're collecting premium (immediate cash!), betting on near-term range before breakout, and the trade PAYS YOU to enter. Max risk defined at spread width minus credit.
Position sizing: 2-5% of portfolio max. If you have $50K, allocate $1,000-2,500.
Exit plan: Take profits at 50-75% max gain. Don't get greedy waiting for expiration.
Best Trade: GLD $96M Bull Call Spread replicated at smaller scale
Your Play:
Why this timeframe works:
Entry timing:
Target profits:
Risk management:
Why this beats stock: Defined risk, no overnight gap risk beyond spread width, leveraged upside if gold rallies.
Best Trade: IWD $8M Put Spread - Sell insurance at strong gamma support
Your Play:
Why this generates income:
Your income breakdown:
Management:
Why this works for income collectors:
Position sizing: 10-15% of portfolio. If you have $100K, allocate $10-15K = 20-30 spreads.
Advanced move: Layer multiple expirations (Dec, Jan, Feb) to smooth income and reduce timing risk.
Best Trade: Own the ETFs directly, learn by watching
Your Play (Safest):
Why ETFs for beginners:
What to watch:
When to sell:
Next step after mastering this: Once comfortable with ETF price action and gamma dynamics, try ONE simple option:
Books to read while holding:
Key principle for beginners: Start small, learn by doing, protect capital. Options are leverage - they magnify both gains AND losses. Master the basics before deploying size.
1. Unusual ≠ Profitable
Just because smart money deployed $333.5M doesn't mean these trades will work. Z-scores measure statistical unusualness (size relative to normal activity), NOT probability of success. Many institutional trades are hedges, portfolio adjustments, or tax-loss harvesting—not directional bets.
Example: The IWD $8M put spread is insurance, not a bearish bet. If markets stay calm and IWD doesn't drop 10%, the trader loses $2.8M (but their $1.54B portfolio gained elsewhere).
Takeaway: Understand the INTENT behind each trade before copying. Is it speculation or protection?
2. Time Horizon Matters Enormously
LEAPS trades (COIN Jan 2027, LHX Jan 2027) have 14+ months to work out. They can withstand 20-30% pullbacks and still profit if the long-term thesis plays out.
Monthly trades (GLD Dec 19, GOOGL Dec 19, PLTR Nov 21) have 11-39 days. They expire worthless if wrong by just a few percentage points or days.
Don't mix timeframes! If you buy GLD Dec calls because you like gold long-term, you're mismatched. Short-dated options require precision timing AND directional accuracy.
Takeaway: Match your timeframe to the trade. Swing traders use monthlies; LEAPS require 12-18 month conviction.
3. Position Sizing is EVERYTHING
Institutional traders risking $1.5M on LHX LEAPS likely have $500M-1B portfolios (0.15-0.3% risk). For them, total loss is rounding error.
For retail traders: If you have $50K portfolio and risk $1,500 (3%) on one LEAPS call, you're taking the SAME relative risk. But you can't afford 10-20 losers in a row like institutions can.
Position sizing rules:
Example: $100K portfolio
Takeaway: Lose small, win big. Survival > home runs.
4. Hidden Risks in Each Trade
GLD $96M: Dollar reversal risk. If U.S. economy stays strong and Fed pauses cuts, dollar rallies, gold drops 5-10% fast.
GOOGL $60M: Antitrust risk. If judge orders breakup (Chrome, Android spin-offs), stock gaps down 15-25%.
PLTR $27.9M: Execution risk. Sold December calls (short volatility). If earnings beat huge and stock gaps to $220, the sold calls explode in value, capping gains.
VST $5.1M: Operational risk. Another Winter Storm Uri (2021 caused $1.6B negative cash flow) gaps stock down 20-30% overnight.
IWD $8M: Recession risk materializing. 40% probability means 60% probability it DOESN'T happen. Paying $2.8M for insurance that may not be needed.
IBB $6.1M: Patent cliff and cash burn. $350-400B in drug revenues losing exclusivity through 2030. 39% of small biotechs have <1 year cash.
Takeaway: Every trade has a "what if it goes wrong" scenario. Identify it BEFORE entering.
5. Emotional Discipline Beats Analysis
The PLTR calendar spread trader collected $12.1M net credit. But if PLTR gaps to $215 on earnings, the emotional pain of capped gains could cause panic selling of the long November calls at exactly the wrong time.
Common emotional mistakes:
Solution:
Takeaway: The best plan executed poorly beats the perfect plan abandoned mid-trade.
6. Patience > Perfection
Smart money has been loading up since August (LHX up 50%, VST up 280%). You're seeing the trades NOW, but they've been building positions for months.
Don't force trades. If you missed VST's run from $49 to $186, don't chase at $186. Wait for:
The market will give you opportunities. There are unusual options trades EVERY SINGLE DAY. Missing one trade doesn't matter if you preserve capital for the next setup.
Takeaway: Patience is a position. Cash is a position. Waiting for YOUR entry > jumping into someone else's trade at their entry + 20%.
This newsletter decodes unusual options activity to help you understand what sophisticated investors are thinking—NOT to blindly copy their trades.
How to use this information:
Remember: The goal isn't to win every trade. The goal is to survive long enough to compound the winners and cut the losers quickly. Professional traders accept 40-60% win rates—they just ensure winners are 2-3x larger than losers.
Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance does not guarantee future results. Unusual options activity reflects statistical measures, not predictions of profitability. Always do your own research and consult a licensed financial advisor before trading.
Ainvest Option Flow Digest is published daily, analyzing institutional options positioning to help retail traders understand smart money flows. Subscribe for daily updates and in-depth analysis.

Nov.28 2025

Nov.26 2025

Nov.25 2025

Nov.24 2025

Nov.21 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet